• Investing
  • Stock
  • Economy
  • Editor’s Pick
Portfolio Performance Today
Stock

Pharma giant AstraZeneca eyes NYSE listing overhaul, keeps London base

by September 29, 2025
by September 29, 2025

AstraZeneca announced plans to change how it lists shares in the United States by moving from American depositary receipts (ADRs) on Nasdaq to a direct listing of its ordinary shares on the New York Stock Exchange.

The decision, revealed on Monday, is part of a broader restructuring of its listing framework to align with its existing presence in London and Stockholm.

The move is intended to simplify access for investors, increase liquidity across markets, and ensure AstraZeneca’s equity remains easily tradable worldwide, while the company continues to be headquartered and taxed in the United Kingdom.

AstraZeneca targets global alignment

The new plan will create a harmonised listing structure that integrates the London Stock Exchange, Nasdaq Stockholm, and the New York Stock Exchange.

Currently, US investors hold AstraZeneca securities through ADRs, which represent underlying shares.

By replacing ADRs with ordinary shares on the NYSE, the company aims to remove an extra layer of complexity in trading while maintaining compliance across different markets.

ADRs are generally less liquid and more difficult to trade than common stock.

Chief executive Pascal Soriot said the move is aimed at “widening the pool of investors in AstraZeneca, especially US domestic institutional and retail investors.”

The decision comes as President Donald Trump steps up pressure on the pharmaceutical industry, threatening steep tariffs on overseas companies that do not expand investment and manufacturing in the US.

The change will not affect AstraZeneca’s headquarters in Cambridge, UK, or its status within the FTSE 100 index.

The company will also remain a constituent of Sweden’s OMX Stockholm 30 index.

AstraZeneca said the plan reflects its goal to balance accessibility for global investors with maintaining its identity as a UK-based multinational pharmaceutical group.

Impact on shareholders and trading

Shareholders will no longer rely on ADRs once the transition to ordinary shares is complete.

This adjustment is designed to give investors in the US access to the same type of equity as those in Europe, removing discrepancies between markets.

By enabling direct participation on one of the world’s largest exchanges, AstraZeneca seeks to strengthen its standing in the US, where it generates a significant portion of its revenue.

The NYSE listing will also place AstraZeneca alongside some of its biggest pharmaceutical competitors that already trade there.

Commitment to UK roots

Despite the shift in US trading arrangements, AstraZeneca confirmed that it will remain headquartered in the UK with its tax base unchanged.

Its inclusion in the FTSE 100 index will continue, ensuring its importance in the London market is preserved.

The company said the harmonisation does not signal a relocation or a change in its operational structure.

Instead, the move is focused on streamlining share access for international investors.

By being listed directly in New York, AstraZeneca expects to bridge gaps between regional investors without compromising its UK commitments.

The post Pharma giant AstraZeneca eyes NYSE listing overhaul, keeps London base appeared first on Invezz

0 comment
0
FacebookTwitterPinterestEmail

previous post
Interview: TikTok’s $14B sale shows politics, not markets, driving valuations, says analyst Mohanad Yakout
next post
Tata Capital IPO aims to raise $1.7B in India’s largest 2025 listing

Related Posts

Cyberattack halts Asahi production, disrupts Japan’s beer supply

October 3, 2025

Europe markets open: Stoxx 600 rises 0.4%, extending...

October 3, 2025

Bitcoin ETFs see over $600M in inflows as...

October 3, 2025

Stockholm leads Europe in IPO activity with $6.8...

October 3, 2025

Indonesia suspends TikTok licence after data refusal during...

October 3, 2025

Why the Thai baht’s climb against US dollar...

October 3, 2025

OpenAI valuation hits $500 billion as employees sell...

October 2, 2025

Here’s why JPMorgan, Morningstar are bullish on Alibaba...

October 2, 2025

Europe markets open: Stoxx 600 jumps 0.6%, led...

October 2, 2025

Will the Tesco share price hit 500p as...

October 2, 2025

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Recent Posts

  • What I Saw in Milei’s Argentina

    October 3, 2025
  • Tariffs Rest on Distrust of Citizens

    October 3, 2025
  • Cyberattack halts Asahi production, disrupts Japan’s beer supply

    October 3, 2025
  • Europe markets open: Stoxx 600 rises 0.4%, extending its record-setting rally

    October 3, 2025
  • Bitcoin ETFs see over $600M in inflows as BTC price nears $120K

    October 3, 2025
  • Stockholm leads Europe in IPO activity with $6.8 billion raised

    October 3, 2025

Editors’ Picks

  • 1

    Meta executives eligible for 200% salary bonus under new pay structure

    February 21, 2025
  • 2

    Walmart earnings preview: What to expect before Thursday’s opening bell

    February 20, 2025
  • 3

    New FBI leader Kash Patel tapped to run ATF as acting director

    February 23, 2025
  • 4

    Cramer reveals a sub-sector of technology that can withstand Trump tariffs

    March 1, 2025
  • 5

    Anthropic’s newly released Claude 3.7 Sonnet can ‘think’ as long as the user wants before giving an answer

    February 25, 2025
  • 6

    Nvidia’s investment in SoundHound wasn’t all that significant after all

    March 1, 2025
  • 7

    Pop Mart reports 188% profit surge, plans aggressive global expansion

    March 26, 2025

Categories

  • Economy (2,770)
  • Editor's Pick (279)
  • Investing (185)
  • Stock (1,885)
  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 Portfolioperformancetoday.com All Rights Reserved.

Portfolio Performance Today
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Portfolio Performance Today
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Copyright © 2025 Portfolioperformancetoday.com All Rights Reserved.

Read alsox

Asia markets open: mixed start follows Fed...

May 8, 2025

FTC seeks delay in Amazon Prime case,...

March 13, 2025

Tourism in Greenland surges 14%: here’s why

March 22, 2025